This report aims to provide a comprehensive presentation of the global market for Cellular Human Tissue-engineered Skin Substitute, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cellular Human Tissue-engineered Skin Substitute. This report contains market size and forecasts of Cellular Human Tissue-engineered Skin Substitute in global, including the following market information:
Global Cellular Human Tissue-engineered Skin Substitute Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global Cellular Human Tissue-engineered Skin Substitute Market Sales, 2018-2023, 2024-2035, (K Units)
Global top five Cellular Human Tissue-engineered Skin Substitute companies in 2022 (%)
The global Cellular Human Tissue-engineered Skin Substitute market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Cellular Allogeneic Segment to Reach $ Million by 2035, with a % CAGR in next six years.
The global key manufacturers of Cellular Human Tissue-engineered Skin Substitute include Allergan (AbbVie), AlloSource, Organogenesis, BD, Smith & Nephew, Integra LifeSciences, Synthes (Johnson & Johnson), Axogen and Vericel Corporation, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cellular Human Tissue-engineered Skin Substitute manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cellular Human Tissue-engineered Skin Substitute Market, by Type, 2018-2023, 2024-2035 ($ Millions) & (K Units)
Global Cellular Human Tissue-engineered Skin Substitute Market Segment Percentages, by Type, 2022 (%)
Cellular Allogeneic
Cellular Autologous
Others
Global Cellular Human Tissue-engineered Skin Substitute Market, by Application, 2018-2023, 2024-2035 ($ Millions) & (K Units)
Global Cellular Human Tissue-engineered Skin Substitute Market Segment Percentages, by Application, 2022 (%)
Hospitals
Specialty Clinics
Wound Care Centers
Global Cellular Human Tissue-engineered Skin Substitute Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions) & (K Units)
Global Cellular Human Tissue-engineered Skin Substitute Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cellular Human Tissue-engineered Skin Substitute revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cellular Human Tissue-engineered Skin Substitute revenues share in global market, 2022 (%)
Key companies Cellular Human Tissue-engineered Skin Substitute sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Cellular Human Tissue-engineered Skin Substitute sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan (AbbVie)
AlloSource
Organogenesis
BD
Smith & Nephew
Integra LifeSciences
Synthes (Johnson & Johnson)
Axogen
Vericel Corporation
LifeNet Health
MTF Biologics
Arthrex
Wright Medical Group NV (Stryker)
Cook Biotech Incorporated
Aroa Biosurgery
Surgalign Holdings
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cellular Human Tissue-engineered Skin Substitute, market overview.
Chapter 2: Global Cellular Human Tissue-engineered Skin Substitute market size in revenue and volume.
Chapter 3: Detailed analysis of Cellular Human Tissue-engineered Skin Substitute manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cellular Human Tissue-engineered Skin Substitute in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cellular Human Tissue-engineered Skin Substitute capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cellular Human Tissue-engineered Skin Substitute Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cellular Human Tissue-engineered Skin Substitute Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cellular Human Tissue-engineered Skin Substitute Overall Market Size
2.1 Global Cellular Human Tissue-engineered Skin Substitute Market Size: 2022 VS 2035
2.2 Global Cellular Human Tissue-engineered Skin Substitute Revenue, Prospects & Forecasts: 2018-2035
2.3 Global Cellular Human Tissue-engineered Skin Substitute Sales: 2018-2035
3 Company Landscape
3.1 Top Cellular Human Tissue-engineered Skin Substitute Players in Global Market
3.2 Top Global Cellular Human Tissue-engineered Skin Substitute Companies Ranked by Revenue
3.3 Global Cellular Human Tissue-engineered Skin Substitute Revenue by Companies
3.4 Global Cellular Human Tissue-engineered Skin Substitute Sales by Companies
3.5 Global Cellular Human Tissue-engineered Skin Substitute Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Cellular Human Tissue-engineered Skin Substitute Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Cellular Human Tissue-engineered Skin Substitute Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cellular Human Tissue-engineered Skin Substitute Players in Global Market
3.8.1 List of Global Tier 1 Cellular Human Tissue-engineered Skin Substitute Companies
3.8.2 List of Global Tier 2 and Tier 3 Cellular Human Tissue-engineered Skin Substitute Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Cellular Human Tissue-engineered Skin Substitute Market Size Markets, 2022 & 2035
4.1.2 Cellular Allogeneic
4.1.3 Cellular Autologous
4.1.4 Others
4.2 By Type - Global Cellular Human Tissue-engineered Skin Substitute Revenue & Forecasts
4.2.1 By Type - Global Cellular Human Tissue-engineered Skin Substitute Revenue, 2018-2023
4.2.2 By Type - Global Cellular Human Tissue-engineered Skin Substitute Revenue, 2024-2035
4.2.3 By Type - Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share, 2018-2035
4.3 By Type - Global Cellular Human Tissue-engineered Skin Substitute Sales & Forecasts
4.3.1 By Type - Global Cellular Human Tissue-engineered Skin Substitute Sales, 2018-2023
4.3.2 By Type - Global Cellular Human Tissue-engineered Skin Substitute Sales, 2024-2035
4.3.3 By Type - Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share, 2018-2035
4.4 By Type - Global Cellular Human Tissue-engineered Skin Substitute Price (Manufacturers Selling Prices), 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cellular Human Tissue-engineered Skin Substitute Market Size, 2022 & 2035
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.1.4 Wound Care Centers
5.2 By Application - Global Cellular Human Tissue-engineered Skin Substitute Revenue & Forecasts
5.2.1 By Application - Global Cellular Human Tissue-engineered Skin Substitute Revenue, 2018-2023
5.2.2 By Application - Global Cellular Human Tissue-engineered Skin Substitute Revenue, 2024-2035
5.2.3 By Application - Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share, 2018-2035
5.3 By Application - Global Cellular Human Tissue-engineered Skin Substitute Sales & Forecasts
5.3.1 By Application - Global Cellular Human Tissue-engineered Skin Substitute Sales, 2018-2023
5.3.2 By Application - Global Cellular Human Tissue-engineered Skin Substitute Sales, 2024-2035
5.3.3 By Application - Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share, 2018-2035
5.4 By Application - Global Cellular Human Tissue-engineered Skin Substitute Price (Manufacturers Selling Prices), 2018-2035
6 Sights by Region
6.1 By Region - Global Cellular Human Tissue-engineered Skin Substitute Market Size, 2022 & 2035
6.2 By Region - Global Cellular Human Tissue-engineered Skin Substitute Revenue & Forecasts
6.2.1 By Region - Global Cellular Human Tissue-engineered Skin Substitute Revenue, 2018-2023
6.2.2 By Region - Global Cellular Human Tissue-engineered Skin Substitute Revenue, 2024-2035
6.2.3 By Region - Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share, 2018-2035
6.3 By Region - Global Cellular Human Tissue-engineered Skin Substitute Sales & Forecasts
6.3.1 By Region - Global Cellular Human Tissue-engineered Skin Substitute Sales, 2018-2023
6.3.2 By Region - Global Cellular Human Tissue-engineered Skin Substitute Sales, 2024-2035
6.3.3 By Region - Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share, 2018-2035
6.4 North America
6.4.1 By Country - North America Cellular Human Tissue-engineered Skin Substitute Revenue, 2018-2035
6.4.2 By Country - North America Cellular Human Tissue-engineered Skin Substitute Sales, 2018-2035
6.4.3 US Cellular Human Tissue-engineered Skin Substitute Market Size, 2018-2035
6.4.4 Canada Cellular Human Tissue-engineered Skin Substitute Market Size, 2018-2035
6.4.5 Mexico Cellular Human Tissue-engineered Skin Substitute Market Size, 2018-2035
6.5 Europe
6.5.1 By Country - Europe Cellular Human Tissue-engineered Skin Substitute Revenue, 2018-2035
6.5.2 By Country - Europe Cellular Human Tissue-engineered Skin Substitute Sales, 2018-2035
6.5.3 Germany Cellular Human Tissue-engineered Skin Substitute Market Size, 2018-2035
6.5.4 France Cellular Human Tissue-engineered Skin Substitute Market Size, 2018-2035
6.5.5 U.K. Cellular Human Tissue-engineered Skin Substitute Market Size, 2018-2035
6.5.6 Italy Cellular Human Tissue-engineered Skin Substitute Market Size, 2018-2035
6.5.7 Russia Cellular Human Tissue-engineered Skin Substitute Market Size, 2018-2035
6.5.8 Nordic Countries Cellular Human Tissue-engineered Skin Substitute Market Size, 2018-2035
6.5.9 Benelux Cellular Human Tissue-engineered Skin Substitute Market Size, 2018-2035
6.6 Asia
6.6.1 By Region - Asia Cellular Human Tissue-engineered Skin Substitute Revenue, 2018-2035
6.6.2 By Region - Asia Cellular Human Tissue-engineered Skin Substitute Sales, 2018-2035
6.6.3 China Cellular Human Tissue-engineered Skin Substitute Market Size, 2018-2035
6.6.4 Japan Cellular Human Tissue-engineered Skin Substitute Market Size, 2018-2035
6.6.5 South Korea Cellular Human Tissue-engineered Skin Substitute Market Size, 2018-2035
6.6.6 Southeast Asia Cellular Human Tissue-engineered Skin Substitute Market Size, 2018-2035
6.6.7 India Cellular Human Tissue-engineered Skin Substitute Market Size, 2018-2035
6.7 South America
6.7.1 By Country - South America Cellular Human Tissue-engineered Skin Substitute Revenue, 2018-2035
6.7.2 By Country - South America Cellular Human Tissue-engineered Skin Substitute Sales, 2018-2035
6.7.3 Brazil Cellular Human Tissue-engineered Skin Substitute Market Size, 2018-2035
6.7.4 Argentina Cellular Human Tissue-engineered Skin Substitute Market Size, 2018-2035
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Revenue, 2018-2035
6.8.2 By Country - Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Sales, 2018-2035
6.8.3 Turkey Cellular Human Tissue-engineered Skin Substitute Market Size, 2018-2035
6.8.4 Israel Cellular Human Tissue-engineered Skin Substitute Market Size, 2018-2035
6.8.5 Saudi Arabia Cellular Human Tissue-engineered Skin Substitute Market Size, 2018-2035
6.8.6 UAE Cellular Human Tissue-engineered Skin Substitute Market Size, 2018-2035
7 Manufacturers & Brands Profiles
7.1 Allergan (AbbVie)
7.1.1 Allergan (AbbVie) Company Summary
7.1.2 Allergan (AbbVie) Business Overview
7.1.3 Allergan (AbbVie) Cellular Human Tissue-engineered Skin Substitute Major Product Offerings
7.1.4 Allergan (AbbVie) Cellular Human Tissue-engineered Skin Substitute Sales and Revenue in Global (2018-2023)
7.1.5 Allergan (AbbVie) Key News & Latest Developments
7.2 AlloSource
7.2.1 AlloSource Company Summary
7.2.2 AlloSource Business Overview
7.2.3 AlloSource Cellular Human Tissue-engineered Skin Substitute Major Product Offerings
7.2.4 AlloSource Cellular Human Tissue-engineered Skin Substitute Sales and Revenue in Global (2018-2023)
7.2.5 AlloSource Key News & Latest Developments
7.3 Organogenesis
7.3.1 Organogenesis Company Summary
7.3.2 Organogenesis Business Overview
7.3.3 Organogenesis Cellular Human Tissue-engineered Skin Substitute Major Product Offerings
7.3.4 Organogenesis Cellular Human Tissue-engineered Skin Substitute Sales and Revenue in Global (2018-2023)
7.3.5 Organogenesis Key News & Latest Developments
7.4 BD
7.4.1 BD Company Summary
7.4.2 BD Business Overview
7.4.3 BD Cellular Human Tissue-engineered Skin Substitute Major Product Offerings
7.4.4 BD Cellular Human Tissue-engineered Skin Substitute Sales and Revenue in Global (2018-2023)
7.4.5 BD Key News & Latest Developments
7.5 Smith & Nephew
7.5.1 Smith & Nephew Company Summary
7.5.2 Smith & Nephew Business Overview
7.5.3 Smith & Nephew Cellular Human Tissue-engineered Skin Substitute Major Product Offerings
7.5.4 Smith & Nephew Cellular Human Tissue-engineered Skin Substitute Sales and Revenue in Global (2018-2023)
7.5.5 Smith & Nephew Key News & Latest Developments
7.6 Integra LifeSciences
7.6.1 Integra LifeSciences Company Summary
7.6.2 Integra LifeSciences Business Overview
7.6.3 Integra LifeSciences Cellular Human Tissue-engineered Skin Substitute Major Product Offerings
7.6.4 Integra LifeSciences Cellular Human Tissue-engineered Skin Substitute Sales and Revenue in Global (2018-2023)
7.6.5 Integra LifeSciences Key News & Latest Developments
7.7 Synthes (Johnson & Johnson)
7.7.1 Synthes (Johnson & Johnson) Company Summary
7.7.2 Synthes (Johnson & Johnson) Business Overview
7.7.3 Synthes (Johnson & Johnson) Cellular Human Tissue-engineered Skin Substitute Major Product Offerings
7.7.4 Synthes (Johnson & Johnson) Cellular Human Tissue-engineered Skin Substitute Sales and Revenue in Global (2018-2023)
7.7.5 Synthes (Johnson & Johnson) Key News & Latest Developments
7.8 Axogen
7.8.1 Axogen Company Summary
7.8.2 Axogen Business Overview
7.8.3 Axogen Cellular Human Tissue-engineered Skin Substitute Major Product Offerings
7.8.4 Axogen Cellular Human Tissue-engineered Skin Substitute Sales and Revenue in Global (2018-2023)
7.8.5 Axogen Key News & Latest Developments
7.9 Vericel Corporation
7.9.1 Vericel Corporation Company Summary
7.9.2 Vericel Corporation Business Overview
7.9.3 Vericel Corporation Cellular Human Tissue-engineered Skin Substitute Major Product Offerings
7.9.4 Vericel Corporation Cellular Human Tissue-engineered Skin Substitute Sales and Revenue in Global (2018-2023)
7.9.5 Vericel Corporation Key News & Latest Developments
7.10 LifeNet Health
7.10.1 LifeNet Health Company Summary
7.10.2 LifeNet Health Business Overview
7.10.3 LifeNet Health Cellular Human Tissue-engineered Skin Substitute Major Product Offerings
7.10.4 LifeNet Health Cellular Human Tissue-engineered Skin Substitute Sales and Revenue in Global (2018-2023)
7.10.5 LifeNet Health Key News & Latest Developments
7.11 MTF Biologics
7.11.1 MTF Biologics Company Summary
7.11.2 MTF Biologics Cellular Human Tissue-engineered Skin Substitute Business Overview
7.11.3 MTF Biologics Cellular Human Tissue-engineered Skin Substitute Major Product Offerings
7.11.4 MTF Biologics Cellular Human Tissue-engineered Skin Substitute Sales and Revenue in Global (2018-2023)
7.11.5 MTF Biologics Key News & Latest Developments
7.12 Arthrex
7.12.1 Arthrex Company Summary
7.12.2 Arthrex Cellular Human Tissue-engineered Skin Substitute Business Overview
7.12.3 Arthrex Cellular Human Tissue-engineered Skin Substitute Major Product Offerings
7.12.4 Arthrex Cellular Human Tissue-engineered Skin Substitute Sales and Revenue in Global (2018-2023)
7.12.5 Arthrex Key News & Latest Developments
7.13 Wright Medical Group NV (Stryker)
7.13.1 Wright Medical Group NV (Stryker) Company Summary
7.13.2 Wright Medical Group NV (Stryker) Cellular Human Tissue-engineered Skin Substitute Business Overview
7.13.3 Wright Medical Group NV (Stryker) Cellular Human Tissue-engineered Skin Substitute Major Product Offerings
7.13.4 Wright Medical Group NV (Stryker) Cellular Human Tissue-engineered Skin Substitute Sales and Revenue in Global (2018-2023)
7.13.5 Wright Medical Group NV (Stryker) Key News & Latest Developments
7.14 Cook Biotech Incorporated
7.14.1 Cook Biotech Incorporated Company Summary
7.14.2 Cook Biotech Incorporated Business Overview
7.14.3 Cook Biotech Incorporated Cellular Human Tissue-engineered Skin Substitute Major Product Offerings
7.14.4 Cook Biotech Incorporated Cellular Human Tissue-engineered Skin Substitute Sales and Revenue in Global (2018-2023)
7.14.5 Cook Biotech Incorporated Key News & Latest Developments
7.15 Aroa Biosurgery
7.15.1 Aroa Biosurgery Company Summary
7.15.2 Aroa Biosurgery Business Overview
7.15.3 Aroa Biosurgery Cellular Human Tissue-engineered Skin Substitute Major Product Offerings
7.15.4 Aroa Biosurgery Cellular Human Tissue-engineered Skin Substitute Sales and Revenue in Global (2018-2023)
7.15.5 Aroa Biosurgery Key News & Latest Developments
7.16 Surgalign Holdings
7.16.1 Surgalign Holdings Company Summary
7.16.2 Surgalign Holdings Business Overview
7.16.3 Surgalign Holdings Cellular Human Tissue-engineered Skin Substitute Major Product Offerings
7.16.4 Surgalign Holdings Cellular Human Tissue-engineered Skin Substitute Sales and Revenue in Global (2018-2023)
7.16.5 Surgalign Holdings Key News & Latest Developments
8 Global Cellular Human Tissue-engineered Skin Substitute Production Capacity, Analysis
8.1 Global Cellular Human Tissue-engineered Skin Substitute Production Capacity, 2018-2035
8.2 Cellular Human Tissue-engineered Skin Substitute Production Capacity of Key Manufacturers in Global Market
8.3 Global Cellular Human Tissue-engineered Skin Substitute Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cellular Human Tissue-engineered Skin Substitute Supply Chain Analysis
10.1 Cellular Human Tissue-engineered Skin Substitute Industry Value Chain
10.2 Cellular Human Tissue-engineered Skin Substitute Upstream Market
10.3 Cellular Human Tissue-engineered Skin Substitute Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cellular Human Tissue-engineered Skin Substitute Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Cellular Human Tissue-engineered Skin Substitute in Global Market
Table 2. Top Cellular Human Tissue-engineered Skin Substitute Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Cellular Human Tissue-engineered Skin Substitute Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Cellular Human Tissue-engineered Skin Substitute Revenue Share by Companies, 2018-2023
Table 5. Global Cellular Human Tissue-engineered Skin Substitute Sales by Companies, (K Units), 2018-2023
Table 6. Global Cellular Human Tissue-engineered Skin Substitute Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Cellular Human Tissue-engineered Skin Substitute Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Cellular Human Tissue-engineered Skin Substitute Product Type
Table 9. List of Global Tier 1 Cellular Human Tissue-engineered Skin Substitute Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cellular Human Tissue-engineered Skin Substitute Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Global Cellular Human Tissue-engineered Skin Substitute Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Cellular Human Tissue-engineered Skin Substitute Revenue (US$, Mn), 2024-2035
Table 14. By Type - Global Cellular Human Tissue-engineered Skin Substitute Sales (K Units), 2018-2023
Table 15. By Type - Global Cellular Human Tissue-engineered Skin Substitute Sales (K Units), 2024-2035
Table 16. By Application ? Global Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2022 & 2035
Table 17. By Application - Global Cellular Human Tissue-engineered Skin Substitute Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Cellular Human Tissue-engineered Skin Substitute Revenue (US$, Mn), 2024-2035
Table 19. By Application - Global Cellular Human Tissue-engineered Skin Substitute Sales (K Units), 2018-2023
Table 20. By Application - Global Cellular Human Tissue-engineered Skin Substitute Sales (K Units), 2024-2035
Table 21. By Region ? Global Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2022 VS 2035
Table 22. By Region - Global Cellular Human Tissue-engineered Skin Substitute Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Cellular Human Tissue-engineered Skin Substitute Revenue (US$, Mn), 2024-2035
Table 24. By Region - Global Cellular Human Tissue-engineered Skin Substitute Sales (K Units), 2018-2023
Table 25. By Region - Global Cellular Human Tissue-engineered Skin Substitute Sales (K Units), 2024-2035
Table 26. By Country - North America Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2024-2035
Table 28. By Country - North America Cellular Human Tissue-engineered Skin Substitute Sales, (K Units), 2018-2023
Table 29. By Country - North America Cellular Human Tissue-engineered Skin Substitute Sales, (K Units), 2024-2035
Table 30. By Country - Europe Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2024-2035
Table 32. By Country - Europe Cellular Human Tissue-engineered Skin Substitute Sales, (K Units), 2018-2023
Table 33. By Country - Europe Cellular Human Tissue-engineered Skin Substitute Sales, (K Units), 2024-2035
Table 34. By Region - Asia Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2024-2035
Table 36. By Region - Asia Cellular Human Tissue-engineered Skin Substitute Sales, (K Units), 2018-2023
Table 37. By Region - Asia Cellular Human Tissue-engineered Skin Substitute Sales, (K Units), 2024-2035
Table 38. By Country - South America Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2024-2035
Table 40. By Country - South America Cellular Human Tissue-engineered Skin Substitute Sales, (K Units), 2018-2023
Table 41. By Country - South America Cellular Human Tissue-engineered Skin Substitute Sales, (K Units), 2024-2035
Table 42. By Country - Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2024-2035
Table 44. By Country - Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Sales, (K Units), 2024-2035
Table 46. Allergan (AbbVie) Company Summary
Table 47. Allergan (AbbVie) Cellular Human Tissue-engineered Skin Substitute Product Offerings
Table 48. Allergan (AbbVie) Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Allergan (AbbVie) Key News & Latest Developments
Table 50. AlloSource Company Summary
Table 51. AlloSource Cellular Human Tissue-engineered Skin Substitute Product Offerings
Table 52. AlloSource Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. AlloSource Key News & Latest Developments
Table 54. Organogenesis Company Summary
Table 55. Organogenesis Cellular Human Tissue-engineered Skin Substitute Product Offerings
Table 56. Organogenesis Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Organogenesis Key News & Latest Developments
Table 58. BD Company Summary
Table 59. BD Cellular Human Tissue-engineered Skin Substitute Product Offerings
Table 60. BD Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. BD Key News & Latest Developments
Table 62. Smith & Nephew Company Summary
Table 63. Smith & Nephew Cellular Human Tissue-engineered Skin Substitute Product Offerings
Table 64. Smith & Nephew Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Smith & Nephew Key News & Latest Developments
Table 66. Integra LifeSciences Company Summary
Table 67. Integra LifeSciences Cellular Human Tissue-engineered Skin Substitute Product Offerings
Table 68. Integra LifeSciences Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Integra LifeSciences Key News & Latest Developments
Table 70. Synthes (Johnson & Johnson) Company Summary
Table 71. Synthes (Johnson & Johnson) Cellular Human Tissue-engineered Skin Substitute Product Offerings
Table 72. Synthes (Johnson & Johnson) Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Synthes (Johnson & Johnson) Key News & Latest Developments
Table 74. Axogen Company Summary
Table 75. Axogen Cellular Human Tissue-engineered Skin Substitute Product Offerings
Table 76. Axogen Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Axogen Key News & Latest Developments
Table 78. Vericel Corporation Company Summary
Table 79. Vericel Corporation Cellular Human Tissue-engineered Skin Substitute Product Offerings
Table 80. Vericel Corporation Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Vericel Corporation Key News & Latest Developments
Table 82. LifeNet Health Company Summary
Table 83. LifeNet Health Cellular Human Tissue-engineered Skin Substitute Product Offerings
Table 84. LifeNet Health Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. LifeNet Health Key News & Latest Developments
Table 86. MTF Biologics Company Summary
Table 87. MTF Biologics Cellular Human Tissue-engineered Skin Substitute Product Offerings
Table 88. MTF Biologics Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. MTF Biologics Key News & Latest Developments
Table 90. Arthrex Company Summary
Table 91. Arthrex Cellular Human Tissue-engineered Skin Substitute Product Offerings
Table 92. Arthrex Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Arthrex Key News & Latest Developments
Table 94. Wright Medical Group NV (Stryker) Company Summary
Table 95. Wright Medical Group NV (Stryker) Cellular Human Tissue-engineered Skin Substitute Product Offerings
Table 96. Wright Medical Group NV (Stryker) Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Wright Medical Group NV (Stryker) Key News & Latest Developments
Table 98. Cook Biotech Incorporated Company Summary
Table 99. Cook Biotech Incorporated Cellular Human Tissue-engineered Skin Substitute Product Offerings
Table 100. Cook Biotech Incorporated Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Cook Biotech Incorporated Key News & Latest Developments
Table 102. Aroa Biosurgery Company Summary
Table 103. Aroa Biosurgery Cellular Human Tissue-engineered Skin Substitute Product Offerings
Table 104. Aroa Biosurgery Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Aroa Biosurgery Key News & Latest Developments
Table 106. Surgalign Holdings Company Summary
Table 107. Surgalign Holdings Cellular Human Tissue-engineered Skin Substitute Product Offerings
Table 108. Surgalign Holdings Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Surgalign Holdings Key News & Latest Developments
Table 110. Cellular Human Tissue-engineered Skin Substitute Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 111. Global Cellular Human Tissue-engineered Skin Substitute Capacity Market Share of Key Manufacturers, 2021-2023
Table 112. Global Cellular Human Tissue-engineered Skin Substitute Production by Region, 2018-2023 (K Units)
Table 113. Global Cellular Human Tissue-engineered Skin Substitute Production by Region, 2024-2035 (K Units)
Table 114. Cellular Human Tissue-engineered Skin Substitute Market Opportunities & Trends in Global Market
Table 115. Cellular Human Tissue-engineered Skin Substitute Market Drivers in Global Market
Table 116. Cellular Human Tissue-engineered Skin Substitute Market Restraints in Global Market
Table 117. Cellular Human Tissue-engineered Skin Substitute Raw Materials
Table 118. Cellular Human Tissue-engineered Skin Substitute Raw Materials Suppliers in Global Market
Table 119. Typical Cellular Human Tissue-engineered Skin Substitute Downstream
Table 120. Cellular Human Tissue-engineered Skin Substitute Downstream Clients in Global Market
Table 121. Cellular Human Tissue-engineered Skin Substitute Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Cellular Human Tissue-engineered Skin Substitute Segment by Type in 2022
Figure 2. Cellular Human Tissue-engineered Skin Substitute Segment by Application in 2022
Figure 3. Global Cellular Human Tissue-engineered Skin Substitute Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cellular Human Tissue-engineered Skin Substitute Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Cellular Human Tissue-engineered Skin Substitute Revenue, 2018-2035 (US$, Mn)
Figure 7. Cellular Human Tissue-engineered Skin Substitute Sales in Global Market: 2018-2035 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Cellular Human Tissue-engineered Skin Substitute Revenue in 2022
Figure 9. By Type - Global Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2022 & 2035
Figure 10. By Type - Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share, 2018-2035
Figure 11. By Type - Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share, 2018-2035
Figure 12. By Type - Global Cellular Human Tissue-engineered Skin Substitute Price (US$/Unit), 2018-2035
Figure 13. By Application - Global Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2022 & 2035
Figure 14. By Application - Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share, 2018-2035
Figure 15. By Application - Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share, 2018-2035
Figure 16. By Application - Global Cellular Human Tissue-engineered Skin Substitute Price (US$/Unit), 2018-2035
Figure 17. By Region - Global Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2022 & 2035
Figure 18. By Region - Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share, 2018 VS 2022 VS 2035
Figure 19. By Region - Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share, 2018-2035
Figure 20. By Region - Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share, 2018-2035
Figure 21. By Country - North America Cellular Human Tissue-engineered Skin Substitute Revenue Market Share, 2018-2035
Figure 22. By Country - North America Cellular Human Tissue-engineered Skin Substitute Sales Market Share, 2018-2035
Figure 23. US Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2035
Figure 24. Canada Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2035
Figure 25. Mexico Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2035
Figure 26. By Country - Europe Cellular Human Tissue-engineered Skin Substitute Revenue Market Share, 2018-2035
Figure 27. By Country - Europe Cellular Human Tissue-engineered Skin Substitute Sales Market Share, 2018-2035
Figure 28. Germany Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2035
Figure 29. France Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2035
Figure 30. U.K. Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2035
Figure 31. Italy Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2035
Figure 32. Russia Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2035
Figure 33. Nordic Countries Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2035
Figure 34. Benelux Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2035
Figure 35. By Region - Asia Cellular Human Tissue-engineered Skin Substitute Revenue Market Share, 2018-2035
Figure 36. By Region - Asia Cellular Human Tissue-engineered Skin Substitute Sales Market Share, 2018-2035
Figure 37. China Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2035
Figure 38. Japan Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2035
Figure 39. South Korea Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2035
Figure 40. Southeast Asia Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2035
Figure 41. India Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2035
Figure 42. By Country - South America Cellular Human Tissue-engineered Skin Substitute Revenue Market Share, 2018-2035
Figure 43. By Country - South America Cellular Human Tissue-engineered Skin Substitute Sales Market Share, 2018-2035
Figure 44. Brazil Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2035
Figure 45. Argentina Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2035
Figure 46. By Country - Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Revenue Market Share, 2018-2035
Figure 47. By Country - Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Sales Market Share, 2018-2035
Figure 48. Turkey Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2035
Figure 49. Israel Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2035
Figure 50. Saudi Arabia Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2035
Figure 51. UAE Cellular Human Tissue-engineered Skin Substitute Revenue, (US$, Mn), 2018-2035
Figure 52. Global Cellular Human Tissue-engineered Skin Substitute Production Capacity (K Units), 2018-2035
Figure 53. The Percentage of Production Cellular Human Tissue-engineered Skin Substitute by Region, 2022 VS 2035
Figure 54. Cellular Human Tissue-engineered Skin Substitute Industry Value Chain
Figure 55. Marketing Channels
